Vaccines biology involves the intricate interplay between the immune system and the components of vaccines designed to induce protective immunity. Vaccines leverage the biological principles of immunology to train the immune system to recognize and combat specific pathogens. Vaccine antigens, derived from viruses, bacteria, or other infectious agents, stimulate the production of antibodies and activate immune cells. Memory cells generated during vaccination provide a rapid and robust response upon subsequent exposure to the actual pathogen, conferring immunological memory. Various vaccine types exist, including live attenuated, inactivated, subunit, and mRNA vaccines, each exploiting different biological mechanisms to elicit immune responses. Live attenuated vaccines mimic natural infections, stimulating strong and long-lasting immunity, while inactivated vaccines utilize killed pathogens to trigger immune responses. Adjuvants, another essential component, enhance the immune response to vaccine antigens. They function by activating immune cells and promoting the production of cytokines, amplifying the overall effectiveness of the vaccine. Understanding the biological principles governing vaccines is pivotal for their design, development, and optimization. Ongoing research in vaccines biology continually refines our knowledge, leading to the creation of safer, more effective vaccines against a broad spectrum of infectious diseases.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe